Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperforin acts as an angiogenesis inhibitor.

Christoph M Schempp1, Judit Kiss, Vladimir Kirkin

  • 1Department of Dermatology, University of Freiburg, Germany. cschempp@haut.ukl.uni-freiburg.de

Planta Medica
|December 2, 2005
PubMed
Summary

Hyperforin, a compound from St. John's Wort, inhibits tumor growth by inducing cancer cell death and suppressing new blood vessel formation (angiogenesis) in both lab studies and animal models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum lactate dehydrogenase is associated with the presence and extent of preoperative peritumoral edema in melanoma brain metastases.

Journal of neuro-oncology·2026
Same author

Diagnostic Accuracy of Ex Vivo Confocal Laser Scanning Microscopy for Routine Detection of Cutaneous Squamous Cell Carcinoma and Actinic Keratoses.

Cancers·2026
Same author

Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study.

Nature cancer·2026
Same author

Disc-Toroid Hybrid Lipid Nanoparticles for Efficient Drug Encapsulation and Subcutaneous Delivery.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Vascular Contractile and Structural Properties in Diet-Induced Atherosclerosis-Prone CB<sub>1</sub>-LDL Receptor Double Knockout Animal Model.

Biomedicines·2026
Same author

Atopic Multimorbidity in Adults With a Focus on Sensitization Patterns and T Cell Activation.

Clinical and translational allergy·2025

Area of Science:

  • Plant-derived compounds
  • Cancer research
  • Angiogenesis inhibition

Background:

  • Hyperforin from Hypericum perforatum induces apoptosis and inhibits tumor cell proliferation.
  • The anti-angiogenic potential of hyperforin remains largely unexplored.

Purpose of the Study:

  • To investigate the anti-angiogenic effects of hyperforin in vitro and in vivo.
  • To determine if hyperforin affects endothelial cell proliferation and microvessel formation.
  • To assess hyperforin's impact on tumor growth and vascularization in a rat model.

Main Methods:

  • In vitro: Assessed hyperforin's effect on human dermal microvascular endothelial cell (HDMEC) microvessel formation and proliferation.
  • In vivo: Evaluated hyperforin's efficacy in Wistar rats bearing MT-450 mammary carcinoma, assessing tumor growth, apoptosis, and vascularization (CD31 staining).

Related Experiment Videos

Main Results:

  • Hyperforin inhibited HDMEC microvessel formation and proliferation in a dose-dependent manner without toxicity or inducing apoptosis.
  • In vivo, hyperforin significantly suppressed tumor growth, induced tumor cell apoptosis, and reduced tumor vascularization.
  • Reduced vascularization was confirmed by decreased CD31-positive microvessels in the tumor stroma.

Conclusions:

  • Hyperforin exhibits anti-angiogenic properties by directly inhibiting endothelial cell function.
  • Hyperforin suppresses tumor growth through both direct tumor cell apoptosis and inhibition of angiogenesis.
  • These findings highlight hyperforin as a potential therapeutic agent targeting both tumor cells and their vascular supply.